Kiniksa Pharmaceuticals International Plc (KNSA)
75.79
+0.57
(+0.76%)
USD |
NASDAQ |
Oct 02, 16:00
75.72
-0.07
(-0.09%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International Shareholders Equity (Quarterly) : 654.15M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 654.15M |
| March 31, 2026 | 605.69M |
| December 31, 2025 | 567.61M |
| September 30, 2025 | 535.38M |
| June 30, 2025 | 495.01M |
| March 31, 2025 | 457.49M |
| December 31, 2024 | 438.44M |
| September 30, 2024 | 437.01M |
| June 30, 2024 | 435.10M |
| March 31, 2024 | 431.90M |
| December 31, 2023 | 438.84M |
| September 30, 2023 | 405.13M |
| June 30, 2023 | 411.66M |
| March 31, 2023 | 390.10M |
| December 31, 2022 | 396.15M |
| September 30, 2022 | 384.01M |
| June 30, 2022 | 153.49M |
| March 31, 2022 | 166.24M |
| Date | Value |
|---|---|
| December 31, 2021 | 185.04M |
| September 30, 2021 | 214.05M |
| June 30, 2021 | 235.78M |
| March 31, 2021 | 270.70M |
| December 31, 2020 | 311.94M |
| September 30, 2020 | 358.51M |
| June 30, 2020 | 250.42M |
| March 31, 2020 | 205.83M |
| December 31, 2019 | 225.42M |
| September 30, 2019 | 251.91M |
| June 30, 2019 | 275.20M |
| March 31, 2019 | 306.52M |
| December 31, 2018 | 279.27M |
| September 30, 2018 | 318.91M |
| June 30, 2018 | 341.80M |
| March 31, 2018 | 205.48M |
| December 31, 2017 | 30.06M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 896.11M |
| Total Liabilities (Quarterly) | 241.96M |
| Debt to Equity Ratio | 0.0136 |
| Current Ratio | 3.904 |
| Net Debt Paydown Yield | 0.00% |